Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women

Nutrition Journal

Kazuhiro Uenishi¹  Leon J Schurgers²  Toshiro Sato³ 

[1]Laboratory of Physiological Nutrition, Kagawa Nutrition University, 3-9-2, Chiyoda, Sakado, Saitama, 350-0288, Japan

[2]Department of Biochemistry, Cardiovascular Research Institute, University Maastricht, Maastricht, The Netherlands

[3]Fine Chemical Laboratory, J-OIL MILLS, INC, 1746 Nakashinden, Fukuroi-city, Shizuoka, 437-1111, Japan

关键词: Absorption;    Bioavailability;    Menaquinone-7;    Menaquinone-4;    Vitamin K₂;   

Others  :  823852
DOI  :  10.1186/1475-2891-11-93

 received in 2012-07-17, accepted in 2012-11-03,  发布年份 2012

【 摘 要 】

Background

Vitamin K₂ contributes to bone and cardiovascular health. Therefore, two vitamin K₂ homologues, menaquinone-4 (MK-4) and menaquinone-7 (MK-7), have been used as nutrients by the food industry and as nutritional supplements to support bone and cardiovascular health. However, little is known about the bioavailability of nutritional MK-4. To investigate MK-4 and MK-7 bioavailability, nutritional doses were administered to healthy Japanese women.

Findings

Single dose administration of MK-4 (420 μg; 945 nmol) or MK-7 (420 μg; 647 nmol) was given in the morning together with standardized breakfast. MK-7 was well absorbed and reached maximal serum level at 6 h after intake and was detected up to 48 h after intake. MK-4 was not detectable in the serum of all subjects at any time point. Consecutive administration of MK-4 (60 μg; 135 nmol) or MK-7 (60 μg; 92 nmol) for 7 days demonstrated that MK-4 supplementation did not increase serum MK-4 levels. However, consecutive administration of MK-7 increased serum MK-7 levels significantly in all subjects.

Conclusions

We conclude that MK-4 present in food does not contribute to the vitamin K status as measured by serum vitamin K levels. MK-7, however significantly increases serum MK-7 levels and therefore may be of particular importance for extrahepatic tissues.

【 授权许可】

   
2012 Sato et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Cranenburg EC, Schurgers LJ, Vermeer C: Vitamin K: The coagulation vitamin that became omnipotent. Thromb Haemost 2007, 98:120-125.
• [2]Schurgers LJ, Vermeer C: Determination of phylloquinone and menaquinones in food. Haemostasis 2000, 30:298-307.
• [3]Groenen-van Dooren MM, Ronden JE, Soute BA, Vermeer C: Bioavailability of phylloquinone and menaquinones after oral and colorectal administration in vitamin K-deficient rats. Biochem Pharmacol 1995, 50:797-801.
• [4]Sato T, Ohtani Y, Yamada Y, Saitoh S, Harada H: Difference in the metabolism of vitamin K between liver and bone in vitamin K-deficient rats. Br J Nutr 2002, 87:307-314.
• [5]Schurgers LJ, Teunissen KJ, Hamulyák K, Knapen MH, Vik H, Vermeer C: Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood 2007, 109:3279-3283.
• [6]Fang Y, Hu C, Tao X, Wan Y, Tao F: Effect of vitamin K on bone mineral density: a meta-analysis of randomized controlled trials. J Bone Miner Metab 2012, 30:60-68.
• [7]Shearer MJ, Newman P: Metabolism and cell biology of vitamin K. Thromb Haemost 2008, 100:530-547.
• [8]Chatrou ML, Reutelingsperger CP, Schurgers LJ: Role of vitamin K-dependent proteins in the arterial vessel wall. Hämostaseologie 2012, 31:251-257.
• [9]Kimura S, Satoh H, Komai M: The roles of intestinal flora and intestinal function on vitamin K metabolism. J Nutr Sci Vitaminol (Tokyo) 1992, 38(suppl):425-428.
• [10]Thijssen HH, Vervoort LM, Schurgers LJ, Shearer MJ: Menadione is a metabolite of oral vitamin K. Br J Nutr 2006, 95:260-6.
• [11]Nakagawa K, Hirota Y, Sawada N, Yuge N, Watanabe M, Uchino Y, Okuda N, Shimomura Y, Suhara Y, Okano T: Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme. Nature 2010, 468:117-121.
• [12]Ichikawa T, Horie-Inoue K, Ikeda K, Blumberg B, Inoue S: Steroid and xenobiotic receptor SXR mediates vitamin K2-activated transcription of extracellular matrix-related genes and collagen accumulation in osteoblastic cells. J Biol Chem 2006, 281:16927-16934.
• [13]Ito A, Shirakawa H, Takumi N, Minegishi Y, Ohashi A, Howlader ZH, Ohsaki Y, Sato T, Goto T, Komai M: Menaquinone-4 enhances testosterone production in rats and testis-derived tumor cells. Lipids Health Dis 2011, 10:158. BioMed Central Full Text
• [14]Schurgers LJ, Vermeer C: Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim Biophys Acta 2002, 1570:27-32.
• [15]Takeuchi A, Masuda Y, Kimura M, Marushima R, Matsuoka R, Hasegawa M, Takahama M, Onuki M: Minimal effective dose of vitamin K2 (menaquinone-4) on serum osteocalcin concentration in Japanese subjects and safety evaluation of vitamin K2 supplemented in calcium tablet. J Jpn Soc Clin Nutr 2005, 26:254-260.
• [16]van Summeren MJ, Braam LA, Lilien MR, Schurgers LJ, Kuis W, Vermeer C: The effect of menaquinone-7 (vitamin K2) supplementation on osteocalcin carboxylation in healthy prepubertal children. Br J Nutr 2009, 102:1171-1178.
• [17]Brugè F, Bacchetti T, Principi F, Littarru GP, Tiano L: Olive oil supplemented with menaquinone-7 significantly affects osteocalcin carboxylation. Br J Nutr 2011, 106:1058-1062.
• [18]Sato T, Kawahara R, Kamo S, Saito S: Comparison of menaquinone-4 and menaquinone-7 in rats. Vitamins (Japan) 2007, 81:377-381.